Westfield Capital Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$126M Buy
1,362,539
+823,349
+153% +$82.7M 0.53% 51
2025
Q4
$55.1M Buy
+539,190
New +$48.2M 0.23% 142
2022
Q4
Sell
-581,589
Closed -$31.3M 234
2022
Q3
$31.3M Buy
581,589
+11,526
+2% +$592K 0.25% 141
2022
Q2
$23M Buy
570,063
+414,721
+267% +$20.5M 0.18% 161
2022
Q1
$10.3M Buy
+155,342
New +$10.6M 0.07% 179

Other funds holding GH

Westfield Capital Management's GH Position: Q1 2026 in Review

Westfield Capital Management increased its Guardant Health (GH) stake by 153% in Q1 2026, buying an estimated $82.7M and bringing the position to 1,362,539 shares worth $126M. The position accounts for 0.53% of the portfolio, ranked #51.

Westfield Capital Management first reported a position in GH in Q1 2022 and has held it in 5 quarters since. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Westfield Capital Management held 1,362,539 shares of Guardant Health worth $126M as of Q1 2026.
  • Westfield Capital Management bought 823,349 Guardant Health shares in Q1 2026, an estimated $82.7M.
  • Guardant Health made up 0.53% of Westfield Capital Management's portfolio in Q1 2026, its #51 holding.
  • Westfield Capital Management first reported a position in Guardant Health in Q1 2022 and has held it in 5 quarters since.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Westfield Capital Management's 13F filing for Q1 2026, filed 11 May 2026.